Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-22

FDA Approved: VIGABATRIN — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approves the original ANDA for Vigabatrin (Amneal Pharmaceuticals NY LLC) for the treatment of infantile spasms and refractory complex partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)